Valuation : Virbac

Market Cap 2.7B 3.13B 2.55B 2.32B 4.33B 296B 4.37B 30.13B 11.69B 151B 11.76B 11.5B 497B P/E 2026 *
15.8x
P/E 2027 * 14.3x
Enterprise Value 2.83B 3.28B 2.66B 2.43B 4.54B 310B 4.57B 31.55B 12.24B 158B 12.31B 12.04B 520B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.69x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-.--% - - 3.13B
-0.39%+0.61%-50.48%-60.36% 31.48B
-2.78%-1.98%+38.36%+98.72% 12.33B
-3.69%-1.53%-15.90%+3.47% 3.83B
-0.47%-0.62%-1.08%+19.11% 3.13B
-3.60%-2.76%+46.90%+30.40% 2B
0.00%-2.67%+14.42%+6.00% 1.9B
-3.81%+5.13%+0.05%+184.55% 1.62B
-3.25%+2.43%-20.28%-9.25% 1.21B
-1.46%-2.32%-10.95%-42.01% 1.03B
Average -2.09%-0.68%+0.12%+25.62% 6.5B
Weighted average by Cap. -1.41%-1.57%-18.71%-5.00%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.46B 1.33B 2.49B 170B 2.51B 17.3B 6.71B 86.83B 6.75B 6.6B 285B 1.65B 1.91B 1.55B 1.41B 2.64B 180B 2.66B 18.37B 7.13B 92.22B 7.17B 7.01B 303B
Net income 171M 198M 161M 147M 275M 18.74B 277M 1.91B 741M 9.58B 745M 729M 31.47B 190M 220M 179M 163M 304M 20.76B 306M 2.11B 820M 10.61B 825M 807M 34.86B
Net Debt 127M 147M 119M 109M 203M 13.88B 205M 1.41B 549M 7.1B 552M 540M 23.31B 75.16M 87.12M 70.8M 64.51M 121M 8.23B 121M 838M 325M 4.21B 327M 320M 13.82B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA